Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Read More > December 1, 2016
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Read More > December 1, 2016
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future Read More > December 1, 2016
Ecstasy research: will increasing observational data aid our understanding of MDMA? Read More > December 1, 2016
Ketamine’s Mechanisms of Rapid Antidepressant Activity: Evidence from Preclinical Studies Read More > November 30, 2016
